World Cancer Research Fund/American Institute for Cancer Research. Continuous update project expert report 2018 – Body fatness and weight gain and the risk of cancer. 2018. dietandcancerreport.org. Accessed 30 Jan 2020.
Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477.
Masters GA, Krilov L, Bailey HH, et al. Clinical cancer advances 2015: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2015;33(7):786–809.
World Health Organization. BMI classification. 2016.
Islami F, Goding Sauer A, Gapstur SM, Jemal A. Proportion of cancer cases attributable to excess body weight by US State, 2011-2015. JAMA Oncol. 2019;5(3):384–92.
World Cancer Research Fund International/American Institute for Cancer Research. Diet, nutrition, physical activity and cancer: a global perspective. 2018. https://www.wcrf.org/dietandcancer/. Accessed 30 Jan 2020.
Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129(7):1708–17.
Kitahara CM, McCullough ML, Franceschi S, et al. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid. 2016;26(2):306–18.
Teras LR, Kitahara CM, Birmann BM, et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol. 2014;166(5):667–76.
World Cancer Research Fund International/American Institute for Cancer Research. Continuous update project report: diet, nutrition, physical activity and colorectal cancer. 2017. http://www.aicr.org/continuous-update-project/reports/colorectal-cancer-2017-report.pdf. Accessed 30 Jan 2020.
Keum N, Greenwood DC, Lee DH, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst. 2015;107(2):djv088.
Steele CB, Thomas CC, Henley SJ, et al. Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2017;66(39):1052–8.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief. 2017;(288):1–8.
Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and severe obesity among adults aged 20 and over: Unites States, 1960–1962 through 2015–2016: National Center for Health Statistics, 2018.
Koroukian SM, Dong W, Berger NA. Changes in age distribution of obesity-associated cancers. JAMA Netw Open. 2019;2(8):e199261.
Berger NA. Young adult cancer: influence of the obesity pandemic. Obesity (Silver Spring). 2018;26(4):641–50.
Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74.
Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):243–74.
Dixon JK, Moritz DA, Baker FL. Breast cancer and weight gain: an unexpected finding. Oncol Nurs Forum. 1978;5(3):5–7.
Levine EG, Raczynski JM, Carpenter JT. Weight gain with breast cancer adjuvant treatment. Cancer. 1991;67(7):1954–9.
Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol. 1993;11(7):1418–29.
Goodwin PJ, Ennis M, Pritchard KI, McCready D, Koo J, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol. 1999;17(1):120–9.
Rock CL, Flatt SW, Newman V, Caan BJ, Haan MN, et al. Factors associated with weight gain in women after diagnosis of breast cancer. Women’s Healthy Eating and Living Study Group. J Am Diet Assoc. 1999;99(10):1212–21.
Demark-Wahnefried W, Rimer BK, Winer EP. Weight gain in women diagnosed with breast cancer. J Am Diet Assoc. 1997;97(5):519–26, 29; quiz 27–8.
van den Berg MM, Winkels RM, de Kruif JT, et al. Weight change during chemotherapy in breast cancer patients: a meta-analysis. BMC Cancer. 2017;17(1):259.
Gross AL, May BJ, Axilbund JE, Armstrong DK, Roden RB, Visvanathan K. Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2015;24(8):1262–9.
Campbell KL, Lane K, Martin AD, Gelmon KA, McKenzie DC. Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer. Cancer Nurs. 2007;30(2):95–100.
Freedman RJ, Aziz N, Albanes D, Hartman T, Danforth D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab. 2004;89(5):2248–53.
Gordon AM, Hurwitz S, Shapiro CL, LeBoff MS. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer. Menopause. 2011;18(11):1244–8.
Harvie M, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat. 2004;83(3):201–10.
Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev. 2011;12(4):282–94.
Nyrop KA, Deal AM, Shachar SS, et al. Weight trajectories in women receiving systemic adjuvant therapy for breast cancer. Breast Cancer Res Treat. 2020;179(3):709–20.
Ingram C, Brown JK. Patterns of weight and body composition in premenopausal women with early stage breast cancer: has weight gain been overestimated? Cancer Nurs. 2004;27(6):483–90.
Raghavendra A, Sinha AK, Valle-Goffin J, Shen Y, Tripathy D, Barcenas CH. Determinants of weight gain during adjuvant endocrine therapy and association of such weight gain with recurrence in long-term breast cancer survivors. Clin Breast Cancer. 2018;18(1):e7–e13.
Reddy SM, Sadim M, Li J, et al. Clinical and genetic predictors of weight gain in patients diagnosed with breast cancer. Br J Cancer. 2013;109(4):872–81.
Kumar N, Allen KA, Riccardi D, et al. Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit? Breast Cancer Res Treat. 2004;83(2):149–59.
Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, et al. Weight change during chemotherapy changes the prognosis in non-metastatic breast cancer for the worse. BMC Cancer. 2010;10(648):1–9.
Bradshaw PT, Ibrahim JG, Stevens J, Cleveland RJ, Abrahamson PE, et al. Postdiagnosis change in bodyweight and survival after breast cancer diagnosis. Epidemiology. 2012;23(2):320–7.
Tredan O, Bajard A, Meunier A, Roux P, Fiorletta I, et al. Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr. 2010;29(2):187–91.
Makari-Judson G, Judson CH, Mertens WC. Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year. Breast. 2007;13(3):258–65.
Nyrop KA, Williams GR, Muss HB, Shachar SS. Weight gain during adjuvant endocrine treatment for early-stage breast cancer: what is the evidence? Breast Cancer Res Treat. 2016;158(2):203–17.
Sedjo RL, Byers T, Ganz PA, et al. Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors. J Cancer Surviv. 2014;8(3):410–8.
Nyrop KA, Deal AM, Lee JT, et al. Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review. Breast Cancer Res Treat. 2017;162(2):375–88.
Nyrop KA, Deal AM, Lee JT, et al. Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopause or something else. Breast Cancer Res Treat. 2018;167(1):235–48.
Befort CA, Austin H, Klemp JR. Weight control needs and experiences among rural breast cancer survivors. Psychooncology. 2011;20(10):1069–75.
Irwin ML, McTiernan A, Baumgartner RN, Bernstein L, Gilliland FD, Ballard-Barbash R. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol. 2005;23(4):774–82.
Saquib N, Flatt SW, Natarajan L, Thomson CA, Bardwell WA, et al. Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the Women’s healthy Eating and Living (WHEL) study. Breast Cancer Res Treat. 2007;105(2):177–86.
Heideman WH, Russell NS, Gundy C, Rookus MA, Voskuil DW. The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors. Eur J Cancer. 2009;45:119–26.
Sadim M, Xu Y, Selig K, et al. A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors. Cancer. 2017;123(13):2413–21. https://doi.org/10.1002/cncr.30628. Epub 2017 Feb 14. PMID: 28195643.
Nyrop KA, Deal AM, Shachar SS, et al. Patient-reported toxicities during chemotherapy regimens in current clinical practice for early breast cancer. Oncologist. 2019;24(6):762–71.
Schmidt ME, Chang-Claude J, Vrieling A, Heinz J, Flesch-Janys D, Steindorf K. Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern. J Cancer Surviv. 2012;6(1):11–9.
Mason C, Alfano CM, Smith AW, et al. Long-term physical activity trends in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1153–61.
Hair BY, Hayes S, Tse CK, Bell MB, Olshan AF. Racial differences in physical activity among breast cancer survivors: implications for breast cancer care. Cancer. 2014;120(14):2174–82.
American Cancer Society. Breast cancer facts & figures 2017–2018. Atlanta: American Cancer Society Inc.; 2017.
DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. Cancer. 2019;69(6):438–51.
Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat. 2012;134(2):769–81.
Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107(12):djv275.
Derks MGM, van de Velde CJH, Giardiello D, et al. Impact of comorbidities and age on cause-specific mortality in postmenopausal patients with breast cancer. Oncologist. 2019;24(7):e467–e74.
Patnaik J, Byers T, Diguiseppi C, Denberg T, Dabelea D. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103(14):1101–11.
Kim A, Scharf K, Senthil M, Solomon N, Garberoglio C, Lum SS. The prevalence of overweight and obesity in a breast clinic population: consideration for weight loss as a therapeutic intervention. Surg Obes Relat Dis. 2014;10(2):348–53.
Hong CC, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. Adv Exp Med Biol. 2015;862:155–75.
Wasif N, Neville M, Gray R, Cronin P, Pockaj BA. Competing risk of death in elderly patients with newly diagnosed stage I breast cancer. J Am Coll Surg. 2019;229(1):30–36.e1.
DeSantis CE, Miller KD, Goding Sauer A, Jemal A, Siegel RL. Cancer statistics for African Americans, 2019. Cancer. 2019;69(3):211–33.
DeSantis CE, Ma J. Breast cancer statistics, 2019. 2019.
Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–38.
Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA. 2018;319(16):1723–5.
DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2016;66(1):31–42.
Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005;2005:1765–72.
Braithwaite D, Tammemagi CM, Moore DH, et al. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009;124(5):1213–9.
Troeschel AN, Liu Y, Collin LJ, et al. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. Int J Epidemiol. 2019;48(6):1897–905.
Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.
Druesne-Pecollo N, Touvier M, Barrandon E, et al. Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies. Breast Cancer Res Treat. 2012;135(3):647–54.
Nechuta S, Chen WY, Cai H, et al. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis. Int J Cancer. 2016;138(9):2088–97.
Jung AY, Hüsing A, Behrens S, et al. Postdiagnosis weight change is associated with poorer survival in breast cancer survivors: a prospective population-based patient cohort study. Int J Cancer. 2021;148(1):18–27.
Aleixo GFP, Williams GR, Nyrop KA, Muss HB, Shachar SS. Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review. Breast Cancer Res Treat. 2019;177(3):569–79.
Rossi F, Valdora F, Bignotti B, Torri L, Succio G, Tagliafico AS. Evaluation of body Computed Tomography-determined sarcopenia in breast cancer patients and clinical outcomes: a systematic review. Cancer Treat Res Commun. 2019;21:100154.
Shachar SS, Deal AM, Weinberg M, et al. Body composition as a predictor of toxicity in patients receiving anthracycline and taxane based chemotherapy for early stage breast cancer. Clin Cancer Res. 2017;23(14):3537–43.
Bradshaw PT, Cespedes Feliciano EM, Prado CM, et al. Adipose tissue distribution and survival among women with nonmetastatic breast cancer. Obesity (Silver Spring). 2019;27(6):997–1004.
Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798–804.
Cespedes Feliciano EM, Chen WY, Lee V, et al. Body composition, adherence to anthracycline and taxane-based chemotherapy, and survival after nonmetastatic breast cancer. JAMA Oncol. 2020;6(2):264–70.
Sedjo RL, Hines LM, Byers T, et al. Long-term weight gain among Hispanic and non-Hispanic White women with and without breast cancer. Nutr Cancer. 2013;65(1):34–42.
Davis SR, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric. 2012;15(5):419–29.
Jung SY, Vitolins MZ, Fenton J, Frazier-Wood AC, Hursting SD, Chang S. Risk profiles for weight gain among postmenopausal women: a classification and regression tree analysis approach. PLoS One. 2015;10(3):e0121430.
Rabin C. Promoting lifestyle change among cancer survivors: when is the teachable moment? Am J Lifestyle Med. 2009;3:369.
Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.
Anderson AS, Mackison D, Boath C, Steele R. Promoting changes in diet and physical activity in breast and colorectal cancer screening settings: an unexplored opportunity for endorsing healthy behaviors. Cancer Prev Res (Phila). 2013;6(3):165–72.
Cohen SS, Matthews CE, Bradshaw PT, et al. Sedentary behavior, physical activity, and likelihood of breast cancer among Black and White women: a report from the Southern Community Cohort Study. Cancer Prev Res (Phila). 2013;6(6):566–76.
Thomson ZO, Reeves MM. Can weight gain be prevented in women receiving treatment for breast cancer? A systematic review of intervention studies. Obes Rev. 2017;18(11):1364–73.
Chaudhry ZW, Brown RV, Fawole OA, et al. Comparative effectiveness of strategies to prevent weight gain among women with and at risk for breast cancer: a systematic review. Springerplus. 2013;2(1):277.
Playdon M, Thomas G, Sanft T, Harrigan M, Ligibel J, Irwin M. Weight loss intervention for breast cancer survivors: a systematic review. Curr Breast Cancer Rep. 2013;5(3):222–46.
Reeves MM, Terranova CO, Eakin EG, Demark-Wahnefried W. Weight loss intervention trials in women with breast cancer: a systematic review. Obes Rev. 2014;15(9):749–68.
Chlebowski RT, Reeves MM. Weight loss randomized intervention trials in female cancer survivors. J Clin Oncol. 2016;34(35):4238–48.
Djuric Z, Mirasolo J, Kimbrough L, et al. A pilot trial of spirituality counseling for weight loss maintenance in African American breast cancer survivors. J Natl Med Assoc. 2009;101(6):552–64.
Ferrante JM, Devine KA, Bator A, et al. Feasibility and potential efficacy of commercial mHealth/eHealth tools for weight loss in African American breast cancer survivors: pilot randomized controlled trial. Transl Behav Med. 2020;10(4):938–48.
Sheppard VB, Hicks J, Makambi K, Hurtado-de-Mendoza A, Demark-Wahnefried W, Adams-Campbell L. The feasibility and acceptability of a diet and exercise trial in overweight and obese black breast cancer survivors: the Stepping STONE study. Contemp Clin Trials. 2016;46:106–13.
Scott E, Daley AJ, Doll H, et al. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: a randomized controlled trial. Cancer Causes Control. 2013;24(1):181–91.
Harris MN, Swift DL, Myers VH, et al. Cancer survival through lifestyle change (CASTLE): a pilot study of weight loss. Int J Behav Med. 2013;20(3):403–12.
Greenlee HA, Crew KD, Mata JM, et al. A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors. Obesity (Silver Spring). 2013;21(1):65–76.
Thomson CA, Stopeck AT, Bea JW, et al. Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets. Nutr Cancer. 2010;62(8):1142–52.
Mefferd K, Nichols JF, Pakiz B, Rock CL. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res Treat. 2007;104(2):145–52.
Djuric Z, DiLaura NM, Jenkins I, et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res. 2002;10(7):657–65.
Spark LC, Reeves MM, Fjeldsoe BS, Eakin EG. Physical activity and/or dietary interventions in breast cancer survivors: a systematic review of the maintenance of outcomes. J Cancer Surviv. 2013;7(1):74–82.
Befort CA, Klemp JR, Sullivan DK, et al. Weight loss maintenance strategies among rural breast cancer survivors: the rural women connecting for better health trial. Obesity (Silver Spring). 2016;24(10):2070–7.
Blatt AD, Roe LS, Rolls BJ. Hidden vegetables: an effective strategy to reduce energy intake and increase vegetable intake in adults. Am J Clin Nutr. 2011;93(4):756–63.
Rolls BJ, Drewnowski A, Ledikwe JH. Changing the energy density of the diet as a strategy for weight management. J Am Diet Assoc. 2005;105(5 Suppl 1):S98–103.
U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans – 8th Edition. 2015. https://health.gov/our-work/food-nutrition/2015-2020-dietary-guidelines/guidelines/. Accessed 18 Feb 2020.
Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62(1):30–67.
Jeurnink SM, Buchner FL, Bueno-de-Mesquita HB, et al. Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2012;131(6):E963–73.
Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479s–85s.
Aune D, Chan DS, Greenwood DC, et al. Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies. Ann Oncol. 2012;23(6):1394–402.
World Cancer Research Fund International. Continuous Update Project: diet, nutrition, physical activity and breast cancer survivors. 2014. http://www.wcrf.org/int/research-we-fund/continuous-update-project-findings-reports/breast-cancer-survivors. Accessed 28 Jun 2016.
Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392–404.
Zeng L, Ruan M, Liu J, et al. Trends in processed meat, unprocessed red meat, poultry, and fish consumption in the United States, 1999–2016. J Acad Nutr Diet. 2019;119(7):1085–98.e12.
Champ CE, Volek JS, Siglin J, Jin L, Simone NL. Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? Int J Breast Cancer. 2012;2012:506868.
Flood JE, Roe LS, Rolls BJ. The effect of increased beverage portion size on energy intake at a meal. J Am Diet Assoc. 2006;106(12):1984–90; discussion 90–1.
Pan A, Hu FB. Effects of carbohydrates on satiety: differences between liquid and solid food. Curr Opin Clin Nutr Metab Care. 2011;14(4):385–90.
Allen NE, Beral V, Casabonne D, et al. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst. 2009;101(5):296–305.
Kwan ML, Kushi LH, Weltzien E, et al. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010;28(29):4410–6.
Mayne ST, Ferrucci LM, Cartmel B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu Rev Nutr. 2012;32:369–90.
Chan DSM, Abar L, Cariolou M, et al. World Cancer Research Fund International: Continuous Update Project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes Control. 2019;30(11):1183–200.
Chen X, Wang Q, Zhang Y, Xie Q, Tan X. Physical activity and risk of breast cancer: a meta-analysis of 38 cohort studies in 45 study reports. Value Health. 2019;22(1):104–28.
Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104:815–40.
Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753–65.
Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635–54.
Zhong S, Jiang T, Ma T, et al. Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies. Eur J Epidemiol. 2014;29(6):391–404.
Battaglini CL, Mills RC, Phillips BL, et al. Twenty-five years of research on the effects of exercise training in breast cancer survivors: a systematic review of the literature. World J Clin Oncol. 2014;5(2):177–90.
Casla S, Lopez-Tarruella S, Jerez Y, et al. Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Res Treat. 2015;153(2):371–82.
Kirkham AA, Bland KA, Sayyari S, Campbell KL, Davis MK. Clinically relevant physical benefits of exercise interventions in breast cancer survivors. Curr Oncol Rep. 2016;18(2):12.
Markes M, Brockow T, Resch KL. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2006;18(4):CD005001.
Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc. 2010;42(7):1409–26.
Godoy-Izquierdo D, Guevara NML, Toral MV, Galvan CT, Ballesteros AS, Garcia JFG. Improvements in health-related quality of life, cardio-metabolic health, and fitness in postmenopausal women after a supervised, multicomponent, adapted exercise program in a suited health promotion intervention: a multigroup study. Menopause. 2017;24(8):938–46.
Zhang X, Li Y, Liu D. Effects of exercise on the quality of life in breast cancer patients: a systematic review of randomized controlled trials. Support Care Cancer. 2019;27(1):9–21.
Furmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016;9:Cd005001.
Lee J. Effects of exercise interventions on breast cancer patients during adjuvant therapy: a systematic review and meta-analysis of randomized controlled trials. Cancer Nurs. 2018;43(2):115–25.
Schmitz KH, Campbell AM. Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer. CA Cancer J Clin. 2019;69(6):468–84.
Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.
Nyrop KA, Deal AM, Choi SK, et al. Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer. Breast Cancer Res Treat. 2018;168(1):43–55.
Hanson ED, Wagoner CW, Anderson T, Battaglini CL. The independent effects of strength training in cancer survivors: a systematic review. Curr Oncol Rep. 2016;18(5):31.
Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003;21:1660–8.
Courneya KS, Segal RJ, Mackey JR, et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol. 2007;25(28):4396–404.
Courneya KS, McKenzie DC, Mackey JR, et al. Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst. 2013;105(23):1821–32.
McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ. 2006;175(1):34–41.
van Waart H, Stuiver MM, van Harten WH, et al. Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol. 2015;33(17):1918–27.
Kirkham AA, Bonsignore A, Bland KA, et al. Exercise prescription and adherence for breast cancer: one size does not FITT all. Med Sci Sports Exerc. 2018;50(2):177–86.
Lakoski SG, Eves ND, Douglas PS, Jones LW. Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol. 2012;9(5):288–96.
Sasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW. A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle. 2015;6(2):115–24.
Nelson NL. Breast cancer-related lymphedema and resistance exercise: a systematic review. J Strength Cond Res. 2016;30(9):2656–65.
Coughlin SS, Caplan LS, Williams V. Home-based physical activity interventions for breast cancer patients receiving primary therapy: a systematic review. Breast Cancer Res Treat. 2019;178(3):513–22.
Covington KR, Hidde MC, Pergolotti M, Leach HJ. Community-based exercise programs for cancer survivors: a scoping review of practice-based evidence. Support Care Cancer. 2019;27(12):4435–50.
Courneya KS, Rogers LQ, Campbell KL, Vallance JK, Friedenreich CM. Top 10 research questions related to physical activity and cancer survivorship. Res Q Exerc Sport. 2015;86(2):107–16.
van der Leeden M, Huijsmans RJ, Geleijn E, et al. Tailoring exercise interventions to comorbidities and treatment-induced adverse effects in patients with early stage breast cancer undergoing chemotherapy: a framework to support clinical decisions. Disabil Rehabil. 2018;40(4):486–96.
Burhenn PS, Bryant AL, Mustian KM. Exercise promotion in geriatric oncology. Curr Oncol Rep. 2016;18(9):58.
Doyle C, Kushi LH, Byers T, Courneya KS, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006;56:323–53.
Denlinger CS, Ligibel JA, Are M, et al. Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2014;12(10):1396–406.
Anderson AS, Key TJ, Norat T, et al. European code against cancer 4th edition: obesity, body fatness and cancer. Cancer Epidemiol. 2015;39 Suppl 1:S34–45.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer – viewpoint of the IARC Working Group. N Engl J Med. 2016;375(8):794–8.
Ligibel JA, Wollins D. American Society of Clinical Oncology obesity initiative: rationale, progress, and future directions. J Clin Oncol. 2016;34(35):4256–60.
Ligibel JA, Alfano CM, Hershman D, et al. Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology statement. J Clin Oncol. 2015;33(33):3961–7.
American Society for Clinical Oncology. Obesity and cancer: a guide for oncology providers. 2014. https://www.asco.org/sites/new-www.asco.org/files/content-files/blog-release/documents/obesity-provider-guide.pdf.
Managing your weight after a cancer diagnosis. Alexandria: American Society of Clinical Oncology; 2014.
Ferrante JM, Seaman K, Bator A, et al. Impact of perceived weight stigma among underserved women on doctor-patient relationships. Obes Sci Pract. 2016;2(2):128–35.
Pearl RL, Walton K, Allison KC, Tronieri JS, Wadden TA. Preference for people-first language among patients seeking bariatric surgery. JAMA Surg. 2018;153(12):1160–2.
Volger S, Vetter ML, Dougherty M, et al. Patients’ preferred terms for describing their excess weight: discussing obesity in clinical practice. Obesity (Silver Spring). 2012;20(1):147–50.
Swift JA, Choi E, Puhl RM, Glazebrook C. Talking about obesity with clients: preferred terms and communication styles of U.K. pre-registration dieticians, doctors, and nurses. Patient Educ Couns. 2013;91(2):186–91.
Fong AJ, Faulkner G, Jones JM, Sabiston CM. A qualitative analysis of oncology clinicians’ perceptions and barriers for physical activity counseling in breast cancer survivors. Support Care Cancer. 2018;26(9):3117–26.
Ligibel JA, Jones LW, Brewster AM, et al. Oncologists’ attitudes and practice of addressing diet, physical activity, and weight management with patients with cancer: findings of an ASCO survey of the oncology workforce. J Oncol Pract. 2019;15(6):e520–8. Jop1900124.
Nyrop KA, Lee JT, Deal AM, Choi SK, Muss HB. Weight-related communications between oncology clinicians and women with obesity at early breast cancer diagnosis: findings from a review of the electronic health record. Nutr Cancer. 2020;72(4):576–83.
Nyrop KA, Deal AM, Williams GR, Guerard EJ, Pergolotti M, Muss HB. Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer. Cancer. 2016;122(3):470–6.
Halilova KI, Pisu M. Healthy lifestyle discussions between healthcare providers and older cancer survivors: data from 12 cancer centers in the Southeastern United States. Cancer Med. 2019;8(16):7123–32.
Kirkham AA, Van Patten CL, Gelmon KA, et al. Effectiveness of oncologist-referred exercise and healthy eating programming as a part of supportive adjuvant care for early breast cancer. Oncologist. 2018;23(1):105–15.
Smith KC, Coa KI, Klassen AC. A qualitative study of dietary discussions as an emerging task for cancer clinicians. SAGE Open Med. 2016;4:2050312116665935.
Beeken RJ, Williams K, Wardle J, Croker H. “What about diet?” A qualitative study of cancer survivors’ views on diet and cancer and their sources of information. Eur J Cancer Care. 2016;25(5):774–83.
Clark LH, Ko EM, Kernodle A, et al. Endometrial cancer survivors’ perceptions of provider obesity counseling and attempted behavior change: are we seizing the moment? Int J Gynecol Cancer. 2016;26(2):318–24.
Tseng JH, Roche KL, Jernigan AM, Salani R, Bristow RE, Fader AN. Lifestyle and weight management counseling in uterine cancer survivors: a study of the uterine cancer action network. Int J Gynecol Cancer. 2015;25(7):1285–91.
Zhang FF, Meagher S, Koch-Weser S, et al. Weight management: perception, interest, and preferences in adult cancer survivors. Clin J Oncol Nurs. 2017;21(1):65–71.
Smith L, Croker H, Fisher A, Williams K, Wardle J, Beeken RJ. Cancer survivors’ attitudes towards and knowledge of physical activity, sources of information, and barriers and facilitators of engagement: a qualitative study. Eur J Cancer Care. 2017;26(4).
Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E. Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000;88(3):674–84.
Fisher BA, Wilkinson L, Valencia A. Women’s interest in a personal breast cancer risk assessment and lifestyle advice at NHS mammography screening. J Public Health (Oxf). 2017;39(1):113–21.
Sutton E, Hackshaw-McGeagh LE, Aning J, et al. The provision of dietary and physical activity advice for men diagnosed with prostate cancer: a qualitative study of the experiences and views of health care professionals, patients and partners. Cancer Causes Control. 2017;28(4):319–29.
Zaleta AK, Neff R, McCann GA, O’Malley DM, Carpenter KM. Perceptions of weight management counseling among gynecologic cancer survivors: opportunities for enhancing survivorship care. Support Care Cancer. 2017;25(5):1537–45.
Goodwin PJ. Obesity and breast cancer outcomes: how much evidence is needed to change practice? J Clin Oncol. 2016;34(7):646–8.
Massetti GM, Dietz WH, Richardson LC. Excessive weight gain, obesity, and cancer: opportunities for clinical intervention. JAMA. 2017;318(20):1975–6.
Frazelle ML, Friend PJ. Optimizing the teachable moment for health promotion for cancer survivors and their families. J Adv Pract Oncol. 2016;7(4):422–33.
Hardcastle SJ, Cohen PA. Effective physical activity promotion to survivors of cancer is likely to be home based and to require oncologist participation. J Clin Oncol. 2017;35(32):3635–7.
Brown JC, Ligibel JA. Putting exercise into oncology practice: state-of-the-science, innovation, and future directions. Cancer J. 2019;25(5):316–9.
Demark-Wahnefried W, Rogers LQ, Alfano CM, et al. Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. 2015;65(3):167–89.
United States Census Bureau. U.S. Census Bureau projections show a slower growing, older, more diverse nation a half century from now. 2012. http://www.census.gov/newsroom/releases/archives/population/cb12-243.html. Accessed 01/10/2014.
Jackson CL, Szklo M, Yeh HC, et al. Black-white disparities in overweight and obesity trends by educational attainment in the United States, 1997-2008. J Obes. 2013;2013:140743.
Liu K, Zhang W, Dai Z, et al. Association between body mass index and breast cancer risk: evidence based on a dose-response meta-analysis. Cancer Manag Res. 2018;10:143–51.
Iyengar NM, Arthur R, Manson JE, et al. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncol. 2019;5(2):155–63.
Shieh Y, Scott CG, Jensen MR, et al. Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype. Breast Cancer Res. 2019;21(1):48.
Ando S, Gelsomino L, Panza S, et al. Obesity, leptin and breast cancer: epidemiological evidence and proposed mechanisms. Cancers (Basel). 2019;11(1):62.
Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L. The association between leptin level and breast cancer: a meta-analysis. PLoS One. 2013;8(6):e67349.
Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem. 2002;277(21):18649–57.
Subbaramaiah K, Morris PG, Zhou XK, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov. 2012;2(4):356–65.
Lega IC, Lipscombe LL. Review: diabetes, obesity, and cancer – pathophysiology and clinical implications. Endocr Rev. 2020;41(1):1–20.
Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010;31(1):83–9.
Allott EH, Hursting SD. Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer. 2015;22(6):R365–86.
Sonnenblick A, Agbor-Rah D, Bradbury I, Di Cosima S, Azim HA. Impact of diabetes, insulin, and metformin use on the outcome of patients with human epidermal growth factor receptor-2 positive primary breast cancer: analysis from the ALTTO PHase III randomized trial. J Clin Oncol. 2017;35(13):1421–9.
Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F. Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort. Eur J Cancer Prev. 2010;19(2):120–5.
Kitahara CM, Berrington de Gonzalez A, Freedman ND, et al. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 2011;29(12):1592–8.
Heng YJ, Hankinson SE, Wang J, Alexandrov LB, Ambrosone CB. The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: the cancer genome atlas network. Cancer Epidemiol Biomark Prev. 2020;29(3):599–605.